This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Wuhan Ll Science and Technology Development Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Daiwu Kang: Innovator in Pharmaceutical Composition
Introduction
Daiwu Kang is a notable inventor based in Hubei, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent.
Latest Patents
Daiwu Kang holds a patent for a pharmaceutical composition. This invention relates to a composition that includes at least one neutral endopeptidase inhibitor or a pharmaceutically acceptable salt or ester thereof, along with at least one compound represented by a specific formula or a pharmaceutically acceptable salt or ester thereof. The composition is designed to be combined with a pharmaceutically acceptable carrier. Notably, the combined administration of these components has shown better medicinal effects than when administered separately. He has 1 patent to his name.
Career Highlights
Daiwu Kang is associated with Wuhan Ll Science and Technology Development Co., Ltd. His work at this company has allowed him to focus on developing innovative pharmaceutical solutions that address various medical needs.
Collaborations
Daiwu Kang has collaborated with notable coworkers, including Yongkai Chen and Liu Hu. Their combined efforts contribute to the advancement of pharmaceutical research and development.
Conclusion
Daiwu Kang's contributions to pharmaceutical innovation highlight his role as a key inventor in the industry. His work continues to influence the development of effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile